Our Network of Consultants

Senior executive and consultant in Life Sciences focused on applying precision diagnostics to liquid biopsies to ascertain the molecular profile of single or multiple cells captured and enriched from blood and cerebral spinal fluid.

Experience:
- Ph.D. in molecular genetics, 20 plus years biotechnology experience in R&D, technology and product development, project and operations management, leading to the design, development, manufacture and commercial launch of RUO products, CE marked, and FDA PMA and 510(k) cleared molecular diagnostic assays.
- Broad knowledge focused on state-of-the-art technologies for application in human and molecular genetics, molecular/immuno-diagnostics, and cell biology, directed toward advancing personalized medicine in rare gene disorder and complex diseases through precision diagnostics.
- Application of strategic and tactical operations to reduce timelines and meet multi-million dollar milestones for the successful launch of multiple products from concept to commercialization.
- Managed R&D, product development, and a P&L for a $230M cell culture business.
- Developed 1 and 5 year strategic road maps for new and mature products.
- High level of interpersonal skills managing multiple disciplines for innovative cross-functional projects, which include R&D, computational biology, phase-gate product development, business and market development, clinical studies, tech transfer to manufacturing for RUO and IVD products under design control, FDA QSR and ISO 13485:2016 compliance in cGMP environments.
- “Roll up sleeves” management style to motivate, lead and mentor individuals, in small and large teams, in multi-national matrix corporations, building organizations from the ground up, and meeting project timelines and financial milestones.
- Presentations to executive management, company boards, scientific meetings, investors and multiple publications in top scientific journals
- 10 issued patents and receipt of $4.4M in NIH grants.
- Broad network of key opinion leaders in human and infectious diseases leading to collaborations and partnerships.

Capabilities:
- Transition research companies and their technologies into product development power houses, converting research projects or Research Use Only (RUO) products for use as Laboratory Developed Tests (LDTs) or In-Vitro Diagnostic (IVD) medical devices.
- Develop end-to-end processes, from feasibility to validation via the IVD (510k or PMA) or LDT route for molecular and cellular diagnostic tests.
- Serve at the intersection of assessing technology in M&As.
- Generate focused strategy plans from Marketing (VOC) to Product Development of VOC generated diagnostic assays, to the transfer of developed assays, to Manufacturing/Operations for the manufacture of medical devices under ISO13485.

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

As a Professor of Chemistry at King's College London and Group Leader at the Francis Crick Institute, following nine years at Oxford University where I was also a Royal Society University Research Fellow, I bring over 20 years of experience at the intersection of biophysics, chemistry, and nanotechnology. My research has pioneered novel approaches in membrane biophysics and single-molecule detection, leading to fundamental breakthroughs in nanopore sensing technology. I have developed four patented innovations in this field, with three successfully licensed to industry partners, including methods that enable five-order magnitude improvements in DNA sequencing throughput.

My expertise spans single-molecule microscopy, membrane protein biophysics, microfluidics, and the development of artificial cell membrane systems. I've developed particular specialization in membrane protein function, interferometric scattering microscopy, and optical single-channel recording, contributing to over 70 peer-reviewed publications. This work has been recognized with multiple honors including election as a Fellow of the Royal Society of Chemistry and the RSC Norman Heatley Award.

As a regular reviewer for leading journals including Science and Nature, I maintain active engagement with cutting-edge developments across biophysics and nanotechnology. I've held appointments at Oxford, Stanford, and Cambridge universities, building a broad international network in academia and industry. My experience includes serving as an invited nominator for the Chemistry Nobel Committee, consulting for biotechnology companies, and maintaining successful research collaborations with leading biotech partners.

My technical knowledge spans patent disputes, particularly those involving biophysics and nanopore sensing technologies, complemented by extensive experience in technology commercialization and independent technical review.

With a distinguished background, which includes a PhD and an eMBA, I seamlessly integrate scientific and technical expertise with a profound understanding of global business strategy in chemistry for the biology, assay development and detection methods.

Innovator with extensive experience and a proven track record of developing successful corporate strategies that increase revenues in the Life Sciences industry. Creative visionary and change agent who identifies growth markets, business drivers and builds collaborative global and cross-functional relationships. Recognized for combining transformational business strategies with supporting business cases, operating plans, budgets, and programs.
EXPERTISE
Strategic Planning | M&A | Financial Analysis | Partnerships and IVs | Market Assessments | Negotiation | Deal Structuring | Due Diligence
APPLICATIONS
Flow cytometry, antibodies, reagents, dyes, instruments ( sorters and analyzers)

30+ years of experience in the Life Sciences Industry, with particular expertise in research tools including antibodies, recombinant proteins and associated kits.
I have a PhD in Immunology, and commercial experience at Board level as Site Director, Commercial Director and Chairman. I have worked with family businesses, listed companies and PE backed companies, and have experience of developing companies to successful trade exits. My focus within industry has always been to identify new opportunities with either technology or with customers, and to execute those as quickly and effectively as possible.
Commercially I have gained in depth experience in a range of roles, and can offer advice in Business Development, Strategy, Operational and Technical areas My in-depth experience includes:-

Business Strategy
Reagent in-licensing and out-licensing
Supply agreements
Business development with major IVD and Pharmaceutical customers
Product development
P&L analysis and responsibility
Quality Systems
Developing and leading Commercial Sales and Marketing teams
Operational expertise and commercial reagent manufacturing

Having worked as a product and commercial manager for 18 years within the life science industry, my focus was always to identify cutting edge technology, applications and novel scientific companies, working with them to present their products to the wider research and IVD markets. With a skillset focused on bringing novel technologies to new markets and working to build diverse, integrated portfolios for platforms, my experience, combined with my scientific knowledge, placed me well to work within Mergers & Acquisitions on both buy side and sell side transactions along with strategic pieces.
Specialities: Biotech & Life science Consultancy, specialising in Business Development, strategy and M&A assistance.
Specialises in understanding how the scientific capabilities of companies can be presented to the life science customer base or utilised to build upon strengths of platforms for inorganic expansion.

40 years of experience working in the Research Tools industry, with focus on commercialization of Antibodies, Proteins and Assays. Have founded and ran my own businesses in the RUO area and successfully exited. Have also invested minority stakes in several RUO companies and sat on various Boards as an NED. Previously worked at Serotec for 25 years, then sat on Boards such as Innova Biosciences, Absolute Antibodies, Medix Biochemica, Cellexus & Oxford Expression Technologies.
Experience in setting up and implementing Distribution channels, marketing plans and full business plans. Helped companies exit.
Specialties: Biotech & Lifescience Consultancy, specialising in Business Development and M&A assistance.
Specialises in matching lifescience business partners (finding distributors & OEM Partners)